Medterra CBD Brand Report Card

Home » CBD Product Quality » CBD Brand Report Cards » Medterra CBD Brand Report Card
BR-019 · Documentation Review

Brand: Medterra. Report-card status: Concern. Medterra provides a public Certificate of Analysis hub, product and package routes to batch information, a 30-day refund policy, and a subscription program with account controls. The current concern is limited to consumer-facing THC wording: current broad-spectrum pages use categorical THC-free and non-intoxication language while Medterra also describes its testing in terms such as non-detect.

Brand Report Card

Check Result Current evidence
COA access Pass Medterra maintains a public Certificates of Analysis page and links testing from current product pages.
Batch matching Pass Medterra says each product maps to a dedicated certificate landing page with batch information, and current seller pages say product QR codes can retrieve batch-specific lab results.
Test-panel coverage Unknown Medterra describes third-party potency and purity testing and public quality-control information, but BR-019 did not inspect a current certificate for every product category or assign a brand-wide contaminant-panel Pass.
Label and product-page clarity Concern Current broad-spectrum pages display THC-Free badges and categorical non-intoxication language, while Medterra’s own educational copy also describes testing that confirms non-detect THC.
THC wording Concern The September 5 CBDCafe audit rated Medterra Concern for THC wording. The September 12 recheck still found categorical THC-free and very-low drug-test-risk language that goes beyond what a laboratory reporting threshold can establish for every person.
Refund terms Pass Medterra’s current FAQ says customers may request a refund of the full purchase price, minus shipping costs, within 30 days of receipt. It says Medterra covers return shipping in most instances.
Subscription cancellation Pass The current Subscribe & Save page advertises 25% savings, free shipping, adjustable frequency, and cancellation controls; current product pages also say cancel anytime with no commitment.
Customer service test Not Tested CBDCafe did not contact Medterra customer service for BR-019.
Regulatory-record search Not Assessed BR-019 does not use an enforcement-record search as a scoring field. This review is based on the seller documentation and audit evidence linked below.
Evidence freshness Pass The original 20-brand audit finding was checked September 5, 2026. Medterra certificate, product, refund, and subscription documentation was rechecked September 12, 2026.

Certificate Access and Batch Traceability

Medterra’s current Certificate of Analysis hub states that each product has a corresponding certificate available through the website and that the record leads to a dedicated landing page containing batch information, ingredient profiles, and quality-control information.

Current Medterra collection pages also say product labels carry QR codes that link to batch-specific lab results. That provides a repeatable package-to-report route for buyers. A successful link still needs the normal identity checks: product, strength, batch, report date, units, reporting limits, and the panels actually present.

Open Medterra Certificates of Analysis · Use CBDCafe’s COA Batch-Match Checklist · Read the CBD COA guide

THC-Free and Non-Detect Wording

The September 5 documentation audit rated Medterra Concern for THC wording, and the September 12 recheck supports keeping that narrow result.

The current Enhanced Relief Broad Spectrum CBD Oil page carries a THC-Free badge and describes the line as THC-free. Its FAQ says the broad-spectrum oil will not get a user high because the products are THC-free. Medterra educational copy about drug testing says isolate batches are confirmed as non-detect for THC and describes broad-spectrum products as carrying virtually no risk of a failed drug test.

A THC-free marketing phrase, a non-detect laboratory result, and a prediction about intoxication or drug-testing outcome are different statements. BR-019 records the wording gap without making a chemistry claim about a batch that was not independently tested by CBDCafe.

View Enhanced Relief Broad Spectrum CBD Oil · View Medterra’s spectrum guide · Read what non-detect means on a COA

Refund and Subscription Terms

Medterra’s current FAQ says a customer who is not satisfied may request a refund of the full purchase price, minus shipping costs, within 30 days of the product received date. The company says it covers return shipping in most instances and directs customers to its return portal or customer service. Purchases made through another distributor or retailer must be handled through the original purchase location.

The current Subscribe & Save page advertises a 25% discount and free shipping, with a frequency the customer can change. Current product pages also say the subscription can be canceled at any time with no commitment.

Read Medterra FAQ and return terms · Read Medterra Subscribe & Save · Compare CBD return and subscription terms

How to Verify Medterra Documentation Now

  1. Use the QR code on the product or open Medterra’s Certificate of Analysis hub.
  2. Confirm the dedicated record names the same product and batch you are checking.
  3. Read the cannabinoid result, units, reporting limits, and contaminant panels rather than relying on a THC-Free badge alone.
  4. Keep non-detect language separate from predictions about intoxication or drug-test outcome.
  5. Recheck the 30-day refund terms and the subscription settings that apply to the order route you are using.

Review Scope

  • Report Card ID: BR-019
  • Review level: Documentation Review
  • Commercial relationship: No commercial tie recorded
  • Customer service test: Not Tested
  • Audit checked: September 5, 2026
  • Seller documentation rechecked: September 12, 2026
  • Current status: Concern
Important: This Brand Report Card evaluates dated public seller documentation and policies. CBDCafe did not purchase, sample, or independently test a Medterra product for BR-019. The report is not an endorsement, medical recommendation, legal opinion, laboratory certification, or guarantee that every Medterra product or future batch will match the reviewed documentation.

Related: All Brand Report Cards · CBD COA Access and Label Quality Report · CBD Return Policies and Subscription Terms · CBD COA Batch-Match Checklist · COA Red-Flag Checker